PriceTargets.com logo

Advanced Medical Solutions Group - AMS Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: GBX 270.25
  • Forecasted Upside: 12.60%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
GBX 240 As of 05/1/2026 12:57 PM ET
+0 (0.00%)

This chart shows the closing price for AMS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Advanced Medical Solutions Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AMS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AMS

Analyst Price Target is GBX 270.25
▲ +12.60% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Advanced Medical Solutions Group in the last 3 months. The average price target is GBX 270.25, with a high forecast of GBX 300 and a low forecast of GBX 246. The average price target represents a 12.60% upside from the last price of GBX 240.

This chart shows the closing price for AMS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 4 investment analysts is to moderate buy stock in Advanced Medical Solutions Group. This rating changed within the last month from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/9/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/7/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/8/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/6/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/2/2026
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/3/2026
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/3/2026

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/9/2026Royal Bank Of CanadaReiterated RatingSector PerformGBX 260 ➝ GBX 260
3/18/2026Berenberg BankReiterated RatingBuyGBX 300
1/15/2026Berenberg BankReiterated RatingBuyGBX 300
9/17/2025Peel HuntReiterated RatingBuyGBX 246
9/17/2025Berenberg BankReiterated RatingBuyGBX 300
7/16/2025Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 275
7/15/2025Berenberg BankReiterated RatingBuyGBX 300
3/19/2025Berenberg BankReiterated RatingBuyGBX 300
1/14/2025Berenberg BankReiterated RatingBuyGBX 300
9/18/2024Berenberg BankReiterated RatingBuyGBX 300
3/27/2024Berenberg BankBoost TargetBuyGBX 290 ➝ GBX 300
9/20/2023Berenberg BankReiterated RatingBuyGBX 290
9/4/2023Berenberg BankLower TargetBuyGBX 310 ➝ GBX 290
3/15/2023Liberum CapitalDowngradeHoldGBX 296
3/15/2023Berenberg BankReiterated RatingBuyGBX 310
(Data available from 5/4/2021 forward)

News Sentiment Rating

0.88 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/3/2026
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/2/2026
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/4/2026
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2026
  • 6 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2026

Current Sentiment

  • 6 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Advanced Medical Solutions Group logo
AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.
Read More

Today's Range

Now: GBX 240
Low: 238
High: 243.50

50 Day Range

MA: GBX 211.46
Low: 191
High: 262.61

52 Week Range

Now: GBX 240
Low: 185.60
High: 272

Volume

362,205 shs

Average Volume

1,473,647 shs

Market Capitalization

£519.37 million

P/E Ratio

53.10

Dividend Yield

1.18%

Beta

0.633

Frequently Asked Questions

What sell-side analysts currently cover shares of Advanced Medical Solutions Group?

The following equities research analysts have issued reports on Advanced Medical Solutions Group in the last twelve months: Berenberg Bank, Deutsche Bank Aktiengesellschaft, Peel Hunt, and Royal Bank Of Canada.
View the latest analyst ratings for AMS.

What is the current price target for Advanced Medical Solutions Group?

0 Wall Street analysts have set twelve-month price targets for Advanced Medical Solutions Group in the last year. Their average twelve-month price target is GBX 270.25, suggesting a possible upside of 12.6%. Berenberg Bank has the highest price target set, predicting AMS will reach GBX 300 in the next twelve months. Peel Hunt has the lowest price target set, forecasting a price of GBX 246 for Advanced Medical Solutions Group in the next year.
View the latest price targets for AMS.

What is the current consensus analyst rating for Advanced Medical Solutions Group?

Advanced Medical Solutions Group currently has 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for AMS.

What other companies compete with Advanced Medical Solutions Group?

Other companies that are similar to Advanced Medical Solutions Group include TalkTalk Telecom Group, Scisys Group, Future Metals, ANGLE and Burning Rock Biotech. Learn More about companies similar to Advanced Medical Solutions Group.

How do I contact Advanced Medical Solutions Group's investor relations team?

Advanced Medical Solutions Group's physical mailing address is Unit A, Premier Park, 33 Road One, WINSFORD, CW7 3RT, United Kingdom. The company's listed phone number is +44-1606-863500. The official website for Advanced Medical Solutions Group is www.admedsol.com. Learn More about contacing Advanced Medical Solutions Group investor relations.